Absci Corporation’s ABSI share price has surged by 17.57%, which has investors questioning if this is right time to sell.

"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...

Needham initiated a Buy rating for Absci (ABSI), noting its AI-powered drug discovery platforms, strategic partnerships, and ...

According to Benzinga Pro, Absci's peer group average for short interest as a percentage of float is 12.92%, which means the company has more short interest than most of its peers. Did you know that ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Absci Co. (NASDAQ:ABSI – Get Free Report) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 15,490,000 shares ...

Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company ...

Fintel reports that on January 22, 2025, Needham initiated coverage of Absci (NasdaqGS:ABSI) with a Buy recommendation.

Equities research analysts at Needham & Company LLC assumed coverage on shares of Absci (NASDAQ:ABSI – Get Free Report) in a ...

On Wednesday, Absci Corp (ABSI) stock saw a modest uptick, ending the day at $4.03 which represents a slight increase of $0.81 or 25.16% from the prior close of $3.22. The stock opened at $3.47 and ...

On Monday, Absci Corp (ABSI) stock saw a decline, ending the day at $3.81 which represents a decrease of $-0.19 or -4.75% from the prior close of $4. The stock opened at $3.88 and touched a low of ...

Needham analyst Gil Blum initiated coverage of Absci (ABSI) with a Buy rating and $9 price target Absci “stands out from the pack due to its ...